The Translational Research Center is featured.
Health & Medicine
WHAT: “Healthy Cities: Healthy Women,” a forum on how the health of women, the health impact of living in an urban environment and the practice of public health intersect.
PHILADELPHIA — Two graduate students from the University of Pennsylvania, along with 13 others from the greater Philadelphia region, have each been awarded an Albert Schweitzer Fellowship.
These students, members of the 2011-12 class of Greater Philadelphia Schweitzer Fellows, will spend the next year addressing health disparities in the region while developing lifelong leadership skills.
National Institute of Nursing Research Director to Speak at Penn Nursing School on the Future of Nursing
WHO: Patricia Grady, Director, National Institute of Nursing Research
WHAT: “The Future of Nursing Science”
WHEN: May 11, 2011
Monica Mainigi of the School of Medicine is mentioned for mentoring a high school student recipient of the Leonore Annenberg Scholarship.
Harvey Rubin of the School of Medicine and the Institute for Strategic Threat Analysis and Response is cited for launching a project to help keep lifesaving vaccines cool in order to stay effective.
PHILADELPHIA – National Institutes of Health (NIH) Director Francis Collins, MD, PhD, will join Penn scientists and physicians in celebrating the opening of the new Translational Research Center (TRC) Tuesday. The TRC is the first medical research building on the Penn campus - and one of the first anywhere - to be physically integrated into facilities for patient care, namely the Perelman Center for Advanced Medicine and the Roberts Proton Therapy Center. Dr.
Penn Study: Black Cardiac Arrest Patients More Apt to Be Admitted to Hospitals With Lowest Survival Rates
PHILADELPHIA – Black cardiac arrest victims are more likely to die when they’re treated in hospitals that care for a large black population than when they’re brought to hospitals with a greater proportion of white patients, according to new research from the University of Pennsylvania School of Medicine. The study is published in the April issue of the American Heart Journal.
A Company’s Two Drugs – at Way Different Price Points – Tied in a Study on Treating Macular Degeneration
Maureen Maguire of the School of Medicine helps lead a national study comparing two macular-degeneration drugs.
National Trial Shows Equal Efficacy of Two Medications Used to Treat Age-Related Macular Degeneration
Age-related macular degeneration (AMD), a disease that damages the retina and can destroy central vision, affects approximately 1.6 million Americans. For the past five years, there has been active debate over treatment options for AMD patients because ophthalmologists have not had accurate data regarding the true efficacy of the most commonly used medication.